MedTrace Logo

Autologous Regenerative Technology (ART) For Wound Healing

NCT03368534 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-05-04

No results posted yet for this study

Summary

The purpose of the study is to provide a more effective method of harvesting skin with minimal or no pain, heal more rapidly with little scarring in an outpatient setting with the use of only local anesthesia.

Conditions

  • Chronic Wounds

Interventions

DEVICE

Autologous Regenerative Technology (ART)

ART device with single-needle, fluid-assisted skin tissue harvesting technology.

Sponsors & Collaborators

Principal Investigators

  • Geoffrey Gurtner, MD · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2022-12-01
Completion
2022-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03368534 on ClinicalTrials.gov